Literature DB >> 32646949

Reply.

Michael F Goldberg1, Morton F Goldberg2, R Cerejo1, A H Tayal3.   

Abstract

Mesh：

Year:  2020        PMID： 32646949      PMCID： PMC7658895          DOI： 10.3174/ajnr.A6686

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  12 in total

Review 1.  Severe Covid-19.

Authors:  David A Berlin; Roy M Gulick; Fernando J Martinez
Journal:  N Engl J Med       Date:  2020-05-15       Impact factor: 91.245

2.  The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance.

Authors:  Alexandra L Phelan; Rebecca Katz; Lawrence O Gostin
Journal:  JAMA       Date:  2020-02-25       Impact factor: 56.272

3.  Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).

Authors:  T Umapathi; Ai Ching Kor; N Venketasubramanian; C C Tchoyoson Lim; Boon Chuan Pang; Tseng Tsai Yeo; Cheng Chuan Lee; Poh Lian Lim; Kuperan Ponnudurai; Khoon Leong Chuah; Puay Hoon Tan; Dessmon Yeng Huoa Tai; Sze Peng Brenda Ang
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

4.  SARS-CoV-2 and Stroke in a New York Healthcare System.

Authors:  Shadi Yaghi; Koto Ishida; Jose Torres; Brian Mac Grory; Eytan Raz; Kelley Humbert; Nils Henninger; Tushar Trivedi; Kaitlyn Lillemoe; Shazia Alam; Matthew Sanger; Sun Kim; Erica Scher; Seena Dehkharghani; Michael Wachs; Omar Tanweer; Frank Volpicelli; Brian Bosworth; Aaron Lord; Jennifer Frontera
Journal:  Stroke       Date:  2020-05-20       Impact factor: 7.914

5.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

6.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.

Authors:  Thomas J Oxley; J Mocco; Shahram Majidi; Christopher P Kellner; Hazem Shoirah; I Paul Singh; Reade A De Leacy; Tomoyoshi Shigematsu; Travis R Ladner; Kurt A Yaeger; Maryna Skliut; Jesse Weinberger; Neha S Dangayach; Joshua B Bederson; Stanley Tuhrim; Johanna T Fifi
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

7.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.

Authors:  Julie Helms; Charles Tacquard; François Severac; Ian Leonard-Lorant; Mickaël Ohana; Xavier Delabranche; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Florence Fagot Gandet; Samira Fafi-Kremer; Vincent Castelain; Francis Schneider; Lélia Grunebaum; Eduardo Anglés-Cano; Laurent Sattler; Paul-Michel Mertes; Ferhat Meziani
Journal:  Intensive Care Med       Date:  2020-05-04       Impact factor: 17.440

8.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

9.  Neurologic Features in Severe SARS-CoV-2 Infection.

Authors:  Julie Helms; Stéphane Kremer; Hamid Merdji; Raphaël Clere-Jehl; Malika Schenck; Christine Kummerlen; Olivier Collange; Clotilde Boulay; Samira Fafi-Kremer; Mickaël Ohana; Mathieu Anheim; Ferhat Meziani
Journal:  N Engl J Med       Date:  2020-04-15       Impact factor: 91.245

10.  Clinical features and treatment of COVID-19 patients in northeast Chongqing.

Authors:  Suxin Wan; Yi Xiang; Wei Fang; Yu Zheng; Boqun Li; Yanjun Hu; Chunhui Lang; Daoqiu Huang; Qiuyan Sun; Yan Xiong; Xia Huang; Jinglong Lv; Yaling Luo; Li Shen; Haoran Yang; Gu Huang; Ruishan Yang
Journal:  J Med Virol       Date:  2020-04-01       Impact factor: 2.327
View more
  1 in total

Review 1.  COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease.

Authors:  Che Mohd Nasril Che Mohd Nassir; Sabarisah Hashim; Kah Keng Wong; Sanihah Abdul Halim; Nur Suhaila Idris; Nanthini Jayabalan; Dazhi Guo; Muzaimi Mustapha
Journal:  Mol Neurobiol       Date:  2021-06-26       Impact factor: 5.590
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.